JP Morgan Chase’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $9.67M | Sell |
|
|||||
|
2023
Q3 | $5.79M | Sell |
|
|||||
|
2023
Q2 | $13.4M | Buy |
|
|||||
|
2023
Q1 | $9.56M | Buy |
|
|||||
|
2022
Q4 | $7.2M | Buy |
|
|||||
|
2022
Q3 | $7.49M | Buy |
|
|||||
|
2022
Q2 | $3.03M | Buy |
|
|||||
|
2022
Q1 | $2.56M | Buy |
|
|||||
|
2021
Q4 | $2.21M | Buy |
|
|||||
|
2021
Q3 | $1.9M | Buy |
|
|||||
|
2021
Q2 | $1.63M | Buy |
|
|||||
|
2021
Q1 | $1.21M | Buy |
|
|||||
|
2020
Q4 | $724K | Buy |
|
|||||
|
2020
Q3 | $465K | Buy |
|
|||||
|
2020
Q2 | $582K | Buy |
|
|||||
|
2020
Q1 | $244K | Buy |
|
|||||
|
2019
Q4 | $113K | Sell |
|
|||||
|
2019
Q3 | $32K | Sell |
|
|||||
|
2019
Q2 | $542K | Buy |
|